BRAF and thyroid gland papillary carcinoma: Additionally, it has been suggested that if any additional factors, such as extrathyroidal invasion, lymph node metastases, or the BRAF V600E mutation, are found, PTMC should be treated as a “larger” papillary thyroid cancer [15].